Targeting prostate cancer through reactive oxygen species: Advances in photothermal and sonodynamic therapies.

Lefta RM, Alshkarchy SS, Ali TF, Jabir MS, Kadhum WR

Open source

DOI
10.1016/j.nano.2025.102881
Published
2026 Jan
Container
Nanomedicine : nanotechnology, biology, and medicine
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.nano.2025.102881,
  title = {Targeting prostate cancer through reactive oxygen species: Advances in photothermal and sonodynamic therapies.},
  author = {Lefta RM and Alshkarchy SS and Ali TF and Jabir MS and Kadhum WR},
  year = {2026},
  journal = {Nanomedicine : nanotechnology, biology, and medicine},
  doi = {10.1016/j.nano.2025.102881},
  url = {https://doi.org/10.1016/j.nano.2025.102881}
}

RIS

TY  - JOUR
TI  - Targeting prostate cancer through reactive oxygen species: Advances in photothermal and sonodynamic therapies.
AU  - Lefta RM
AU  - Alshkarchy SS
AU  - Ali TF
AU  - Jabir MS
AU  - Kadhum WR
PY  - 2026
JO  - Nanomedicine : nanotechnology, biology, and medicine
DO  - 10.1016/j.nano.2025.102881
UR  - https://doi.org/10.1016/j.nano.2025.102881
ER  - 

APA

RM, L., SS, A., TF, A., MS, J., & WR, K. (2026). Targeting prostate cancer through reactive oxygen species: Advances in photothermal and sonodynamic therapies.. Nanomedicine : nanotechnology, biology, and medicine. https://doi.org/10.1016/j.nano.2025.102881

Source records